Practical guides spanning vector design through commercialization
27 critical checkpoints that catch regulatory red flags before you generate a single data point. Covers capsid, promoter, transgene, ITR integrity, and CMC readiness.
A systematic scorecard for evaluating and ranking therapeutic targets — balancing scientific rationale, competitive landscape, and commercial potential.
A lean, milestone-driven framework for designing IND-enabling preclinical studies that generate investor-credible data without burning unnecessary runway.
Evaluate your manufacturing readiness across production platform, analytics, process development, and regulatory compliance — before you commit to a CDMO.
Deep-dive connecting the uniQure AMT-130 rejection to the FDA's Plausible Mechanism Pathway — your strategic playbook for navigating regulatory reality.
Navigating the unique challenges of gene therapy clinical design — from dose escalation to long-term follow-up, endpoint selection, and patient stratification.
The step-by-step guide to moving your cell & gene therapy research from academic proof-of-concept to a funded commercial programme — covering IP, team-building, and investor readiness.
Our expert consultants are ready to help you navigate your specific challenges.
Book a Free Discovery Call